Increased serum GHBP levels in obese pubertal children and adolescents: Relationship to body composition, leptin and indicators of metabolic disturbances

International Journal of Obesity

Volumn 21, Issue 12, 1997, Pages 1130-1136

  Kratzsch, J ^a   Dehmel, B ^a   Pulzer, F ^a   Keller, E ^a   Englaro, P ^b   Blum, W F ^b,c   Wabitsch, M ^d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c LILLY DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Growth hormone binding protein; Leptin; Lipoproteins; Obesity

Indexed keywords

CHOLESTEROL; GROWTH HORMONE BINDING PROTEIN; INSULIN; LEPTIN; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY FAT; CHILD; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; IMPEDANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030728676     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800526     Document Type: Article

References (35)

1. Baumann G, Stolar M, Amburn K, Barsano CP, De Vries BC. A specific growth hormone-binding protein in human plasma: Initial characterization. J Clin Endocrinol Metab 1986; 62: 134-141.
2. Herrington AC, Ymer S, Stevenson J. Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 1986; 77: 1817-1823.
3. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987; 330: 537-543.
4. Sotiropoulos A, Goujon L, Simonin G, Kelly PA, Postel-Vinay MC, Finidori J. Evidence for generation of growth hormone-binding protein through proteolysis of the growth hormone receptor. Endocrinology 1993; 132: 1863-1865.
5. Daughaday WH, Trivedi B, Andrews BA. The ontogeny of serum growth hormone binding protein in man: a possible indicator of hepatic GH receptor development. J Clin Endocrinol Metab 1987; 65: 1072-1074.
6. Kratzsch J, Blum WF, Schenker E, Keller E. Regulation of growth hormone (GH), insulin-like growth factor (IGF-I), IGF binding proteins -1,-2,-3 and GH binding protein during progression of liver cirrhosis. Exp Clin Endocrinol 1995; 103: 285-291.
7. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA, Rosenfeld R. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metabolism 1993; 77: 1465-1471.
8. Carlsson LM, Attie KM, Compton PG, Vitangol RV, Merimee TJ. Reduced concentration of serum growth hormone-binding protein in children with idiopatic short stature. J Clin Endocrinol Metab 1994; 78: 1325-1330.
9. Kratzsch J, Schreiber G, Selisko T, Keller E, Pflaum CD, Strasburger CJ. Measurement of serum exon3-retaining growth hormone-binding protein in children and adolescents by RIA. Horm Res 1997, in press.
10. Holl RW, Snehotta R, Siegler B, Scherbaum W, Heinze E. Binding protein for human growth hormone: effects of age and weight. Horm Res 1991; 35: 190-197.
11. Postel-Vinay MC, Saab Ch, Gourmelen M. Nutritional status and growth hormone binding protein. Horm Res 1995; 44: 177-181.
12. Martha PMJ, Rogol AD, Blizzard RM, Shaw MA, Baumann G. Growth hormone binding protein activity is inversely related to 24-hour growth hormone release in normal boys. J Clin Endocrinol Metab 1991; 73: 175-181.
13. Vanderschueren-Lodeweyckx M. The effect of simple obesity on growth and growth hormone. Horm Res 1993; 40: 23-30.
14. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim MBH, Amit T. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I(IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992; 41: 106-112.
15. Rolland-Cachera RC, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad V. Adiposity indices in children. Am J Clin Nutr 1982; 36: 178-184.
16. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-431.
17. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424-3427.
18. Takahashi M, Funahashi T, Shimomura I, Miyaoka K, Matsuzawa Y. Plasma leptin level and body fat distribution. Horm Metab Res 1996; 28: 751-752.
19. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
20. Hebebrand J, Heseker H, Himmelmann W, Schäfer H, Remschmidt H. Altersperzentilen für den Body-Mass-Index aus Daten der Nationalen Verzehrstudie einschließlich einer Übersicht zu relevanten Einflußfaktoren. Akt Ernähr Med 1994; 19: 259-265.
21. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age. Helvet. Paed. Acta 1989, Suppl. 52: 38-39.
22. Wabitsch M, Hauner H, Heinze E, Muche R, Böckmann A, Parthon W, Mayer H, Teller W. Body fat distribution and changes in the atherogenic risk-factor profile in obese adolescent girls during weight reduction. Am J Clin Nutr 1994; 69: 54-60.
23. Kratzsch J, Blum WF, Schenker E, Keller E, Jahreis G, Haustein B, Ventz M, Rotzsch W: Measurement of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: experience with a new enzyme immunoassay. Exp Clin Endocrinol 1993; 101: 144-149.
24. Scholz GH, Englaro P, Thiele I, Scholz M, Klusmann T, Kellner K, Rascher W, Blum WF: Dissociation of serum leptin concentration and body fat content during long term dietary interventions. Horm Metab Res 1996; 28: 718-723.
25. Kratzsch J, Blum WF, Ventz M, Selisko T, Birkenmeyer G, Keller E. Growth hormone-binding protein related immunoreactivity in the serum of patients with acromegaly is inversely regulated by growth hormone concentration. Eur J Endocrinol 1995; 132: 306-312.
26. Fisker S, Vahl N, Jørgensen JOL, Christiansen JS, Ørskov H. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults. J Clin Endocrinol Metab 1997; 81: 123-128.
27. Rasmussen MH, Ho KY, Kjems L: Serum growth hormone binding protein in obesity: effect of a short term, very low calorie diet and diet-induced weight loss. J Clin Endocrinol Metab 1996; 81: 1519-1524.
28. Clark RG, Mortensen L, Carlsson LMS, Spencer SA, McKay P, Mulkerrin M, Moore J, Cunningham BC. Recombinant human growth hormone (GH)-binding protein enhances the growth promoting activity of human GH in rats. Endocrinology 1996; 137: 4308-4315.
29. Baumann G. Growth hormone binding protein-errant receptor or active player? Endocrinology 1995, 136: 377-378.
30. Stem MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovaskular desease. Arteriosclerosis 1986; 6: 123-130.
31. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.
32. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C: Regional distribution of body fat, plasma lipoproteins and cardiovascular disease. Arteriosklerosis 1990; 10: 497-511.
33. Marin P, Kvist H, Lindstedt G, Sjöström L, Björntorp P. Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes 1993; 17: 83-89.
34. Johannsson, Marin P, Lönn L, Ottosson M, Stenlöf K, Björntorp P, Sjöström L, Bengtsson BA. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metaboism, and reduces diastolic blood pressure. J Endocrinol Metab 1997; 82: 727-734.
35. Björntorp P. Visceral obesity: a 'civilisation syndrome'. Obes Res 1993; 1: 206-222.